NETWORK BIO
LIVE

Serial Number

50054658

Owner

Network.bio Inc

Attorney

Alyssa M. Worsham

Filing Date

Aug 17, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NETWORK BIO Trademark

Serial Number: 50054658

NETWORK BIO is a trademark filed by Network.bio Inc on August 17, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Network.bio Inc

3350 W Bayshore Road
Palo Alto, CA 94303

Entity Type: 03

Trademark Details

Filing Date

August 17, 2026

Registration Date

Not Registered

Goods & Services

Financial services, namely, capital investment in biobanking and biomedical data infrastructure

Medical diagnostic preparations, reagents, and assays for testing of body fluids; Medical diagnostic test kits consisting primarily of preparations, reagents, and assays for testing of body fluids; Pharmaceutical preparations for use in the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, hematological, oncological, and viral diseases and disorders

Downloadable computer software for creating and deploying biomedical AI models that generalize across disease and modality; Downloadable computer software for collecting, storing, organizing, analyzing, and interpreting biomedical data to provide clinical insights; Downloadable computer software for use in medical diagnosis, medical treatment, drug discovery, biomarker identification, patient recruiting for clinical trials, and precision medicine research; Downloadable computer software for use in evaluating the effectiveness of medical treatments; Downloadable computer software using artificial intelligence software for biomedical, genomic, and clinical data analysis; Downloadable computer software using artificial intelligence software for clinical informatics and biomedical data warehousing; Downloadable computer software for analyzing health information in support of making clinical decisions in the medical field; Downloadable computer software for training and simulating artificial intelligence models; Downloadable computer software for application and database integration; Downloadable computer software for use as an application programming interface (API); Downloadable computer software for natural language processing, generation, understanding, reasoning, and analysis

Software as a service (SaaS) services featuring software for creating and deploying biomedical AI models that generalize across disease and modality; Software as a service (SaaS) services featuring software for collecting, storing, organizing, analyzing, and interpreting biomedical data to provide clinical insights; Software as a service (SaaS) services featuring software for use in medical diagnosis, medical treatment, drug discovery, biomarker identification, patient recruiting for clinical trials, and precision medicine research; Software as a service (SaaS) services featuring software for use in evaluating the effectiveness of medical treatments; Software as a service (SaaS) services featuring artificial intelligence software for biomedical, genomic, and clinical data analysis; Software as a service (SaaS) services featuring artificial intelligence software for clinical informatics and biomedical data warehousing; Software as a service (SaaS) services featuring software for analyzing health information in support of making clinical decisions in the medical field; Software as a service (SaaS) services featuring software for training and simulating artificial intelligence models; Software as a service (SaaS) services featuring software for application and database integration; Software as a service (SaaS) services featuring software for use as an application programming interface (API); Software as a service (SaaS) services featuring software for natural language processing, generation, understanding, reasoning, and analysis; Research and development services in the fields of computational biology, predictive analytics, artificial intelligence, computer science, multi-modal computer natural language processing, machine learning, and computer software design and development; Research, design and development of computer software; Medical research services; Medical and scientific research in the fields of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, hematological, oncological, and viral diseases and disorders; Pharmaceutical research and development services; Conducting clinical trials for others; Advisory and consultancy services relating to the aforesaid

Recruiting patients for participation in clinical trials for the testing of drugs; Providing referrals of subjects for enrollment in clinical trials; Business consulting and management in the field of clinical trials and decentralized clinical trials; Providing technical consulting services in the field of marketing and advertising for clinical trials; Verifying clinical trial subject eligibility for clinical trials, clinical trial subject recruitment and enrollment for clinical trials; Processing business documents relating to clinical trials; Information management services, namely, clinical data management to medical, pharmaceutical and technology companies in order to assist them with clinical research, clinical trials and applications for drug approval

Medical diagnostic testing services; Medical laboratory testing services to patients for diagnostic and treatment purposes; Providing clinical medical information relating to clinical services; Advisory and consultancy services relating to the aforesaid

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 17, 2026 MAFR
NEW APPLICATION ENTERED
Aug 17, 2026 NWAP